3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
pembrolizumab
3
Paclitaxel
3
Carboplatin
3
niraparib
2
anlotinib
2
Pemetrexed
2
Palliative Care
2
Interviews as Topic
2
Gemcitabine
2
Educational Status
2
Bevacizumab
2
temsirolimus
1
relacorilant
1
olaparib
1
nilotinib
1
liposomal doxorubicin
1
lenvatinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Topotecan
1
Therapeutic Touch
1
Radiotherapy
1
Pregnancy Tests
1
Ocoxin
1
Nivolumab
1
Methods
1
Laparoscopy
1
Human Papillomavirus DNA Tests
1
Fulvestrant
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Genital Neoplasms, Female
×
Pregnancy Tests
×
Gynecologic
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled